logo
Medical news
of the North Caucasus
Scientific journal
Mass media registration certificate dated December 7, 2006.
Series ПИ #ФС 77-26521.
Federal service for surveillance over non-violation of the legislation in the sphere of mass communications and protection of cultural heritage.
ISSN 2073-8137
rus
русский
eng
english

Site search



Correspondence address
310 Mira Street, Stavropol, Russia, 355017

Tel
+7 8652 352524; +7 8652 353229.

Fax
+7 8652 352524.

E-mail
medvestnik@stgmu.ru

Irritable bowel syndrome with concomitant diseases of the stomach and esophagus (overlap syndrome): clinical and immunomorphological characteristics

[Original research] [Internal diseases]
Andrey Svistunov; Mikhail Osadchuk; Natalia Kireeva; Valeriya Burdina; Aleksey Osadchuk; Alisa Lasareva;

Based on the indices of the functioning of the diffuse neuroendocrine system (DNES) of the digestive tract, the features of the formation of irritable bowel syndrome with extraintestinal manifestations are studied. We estimated the role of the endocrine cells of the mucous membrane of the sigmoid colon and the antrum of the stomach producing motilin (MT), vasointestinal hormone (VIH) and somatostatin (SS), in the onset and course of irritable bowel syndrome with extraintestinal manifestations. The relationship between the patient’s psychological status, his neuroendocrine system and extraintestinal manifestations of the disease is demonstrated.

Download

References:
1. Goryacheva E. E. Structure of depressive disorders in the case of patients with funcational gastrointestinal pathology. Meditsinskii al’manakh. – Medical almanac. 2015;1(36):30-33. (In. Russ.).
2 Komarov F. I Osadchuk M. A., Osadchuk A. M. Prakticheskaya gastroenterologiya. Moskva: «Meditsinskoe informatsionnoe agentstvo», 2010. (In Russ.).
3. Osadchuk M. A., Burdina V. O. Syndrome of irritated intestine with extraintestinal manifestations from the positions of neuroendocrine pathology. Eksperimentalnaya i klinicheskaya gastroenterologiya. – Experimental and Clinical Gastroenterology Journal. 2015;114(2):29-34. (In Russ.).
4. Pasechnikov V. D., Golub I. V. Gastroesophageal reflux disease and functional dyspepsia overlap syndrome: prevalence, risk factors and predictors. Klinicheskiye perspektivy gastroenterologii, gepatologii. – Clinical prospects of gastroenterology, gepatology. 2014;6:3-10. (In Russ.).
5. Carabotti M., Scirocco A., Maselli M. A., Severy C. The gut-brain axis: interactions between enteric microbiota, central and enteric nervous systems. Ann. Gastroenterol. 2015;28(2):203-209.
6. Corsetti M., Caenepeel P., Fischler B., Janssens J., Tack J. Impact of Coexisting Irritable Bowel Syndrome on Symptoms and Pathophysiological Mechanisms in Functional Dyspepsia. The American Journal of Gastroenterology. 2004;99(6):1152-1159. https://doi.org/10.1111/j.1572-0241.2004.30040.x
7. Drossman D., Hasler W. Rome IV – Functional GI Disorders: Disorders of Gut-Brain Interaction. Gastroenterology. 2016;150(6):1257-1261. https://doi.org/10.1053/j.gastro.2016.03.035
8. Friesen C. A., Rosen J. M., Schurman J. V. Prevalence of overlap syndromes and symptoms in pediatric functional dyspepsia. BMC Gastroenterology. 2016; 16(1):1. https://doi.org/10.1186/s12876-016-0495-3
9. Ghoshal U. C. Pros and Cons While Looking Through an Asian Window on the Rome IV Criteria for Irritable Bowel Syndrome: Pros. Journal of Neurogastroenterology and Motility. 2017;23(3):334-340. https://doi.org/10.5056/jnm17020
10. Halder S., Locke G., Schleck C., Zinsmeister A., Melton L., Talley N. Natural History of Functional Gastrointestinal Disorders: A 12-year Longitudinal Population-Based Study. Gastroenterology. 2007;133(3):799-807.e1. https://doi.org/10.1053/j.gastro.2007.06.010
11. Jeong J., Choi M., Cho Y., Lee S., Oh J., Park J., Cho Y., Lee I., Kim S., Han S., Choi K., Chung I. Chronic gastrointestinal symptoms and quality of life in the Korean population. World Journal of Gastroenterology. 2008;14(41):6388. https://doi.org/10.3748/wjg.14.6388
12. Johanson J. F., Kralstein J. Chronic constipation: a survey of the patient perspective. Alimentary Pharmacology & Therapeutics. 2007;25(5):599-608. https://doi.org/10.1111/j.1365-2036.2006.03238.x
13. Kazutoshi Hori, Takayuki Matsumoto, Hiroto Miwa. Analysis of the Gastrointestinal Symptoms of Uninvestigated Dyspepsia and Irritable Bowel Syndrome. Gut and Liver. 2009;3(3):192-196. https://doi.org/10.5009/gnl.2009.3.3.192
14. Keohane J., Quigley E. M. Functional dyspepsia and nonerosive reflux disease: clinical interactions and their implications. Med. Gen. Med. 2007;9(3):31.
15. Liang C., Luo H., Liu Y., Cao J., Xia H. Plasma Hormones Facilitated the Hypermotility of the Colon in a Chronic Stress Rat Model. PLoS ONE. 2012;7(2):e31774. https://doi.org/10.1371/journal.pone.0031774
16. Lix L. M., Graff L. A., Walker J. R., Clara I., Rawsthorne P., Rogala L., Miller N., Ediger J., Pretorius T., Bernstein C. N. Longitudinal study of quality of life and psychological functioning for active, fluctuating, and inactive disease patterns in inflammatory bowel disease. Inflammatory Bowel Diseases. 2008;14(11):1575-1584. https://doi.org/10.1002/ibd.20511
17. Park K. S., Jee S. R., Lee B. E., Hong K. S., Shin J. E., Na S., Kwon J. G., Choi S. C., Kim Y. S., Lee H. S., Lee T. H., Kim K. O., Choi J., Moon H. S., Kim Y. S., Park M. I., Park S. J., Park S., Hong S.N. Nationwide Multicenter Study for Overlaps of Common Functional Gastrointestinal Disorders in Korean Patients With Constipation. Journal of Neurogastroenterology and Motility. 2017;23(4):569-577. https://doi.org/10.5056/jnm17033
18. Piessevaux H., De Winter B., Louis E., Muls V., de Looze D., Pelckmans P., Deltenre M., Urbain D., Tack J. Dyspeptic symptoms in the general population: a factor and cluster analysis of symptom groupings. Journal of eurogastroenterology and Motility. 2009;21(4):378-388.https://doi.org/10.1111/j.1365-982.2009.01262.x
19. Schurman J., Friesen C., Danda C., Andre L., Welchert E., Lavenbarg T., Cocjin J., Hyman P. Diagnosing Functional Abdominal Pain with the Rome II Criteria: Parent, Child, and Clinician Agreement. Journal of Pediatric astroenterology and Nutrition. 2005;41(3):291-295. https://doi.org/10.1097/01.mpg.0000178438.64675.c4
20. Sood R., Ford A. Rome IV criteria for FGIDs – an improvement or more of the same? Nature Reviews Gastroenterology and Hepatology. 2016;13(9):501-502. https://doi.org/10.1038/nrgastro.2016.110
21. Sundberg R., Palmqvist M., Tunsäter A., Torén K. Health-related quality of life in young adults with asthma. Respiratory Medicine. 2009;103(10):1580-1585. https://doi.org/10.1016/j.rmed.2009.04.023
22. Vakil N., Stelwagon M., Shea E., Miller S. Symptom burden and consulting behavior in patients with overlapping functional disorders in the US population. United European Gastroenterology Journal. 2015;4(3):413-422. https://doi.org/10.1177/2050640615600114
23. Van Oudenhove L., Vandenberghe J., Vos R., Holvoet L., Tack J. Factors associated with co-morbid irritable bowel syndrome and chronic fatigue-like symptoms in functional dyspepsia. Neurogastroenterology and Motility. 2011;23(6):524-e202. https://doi.org/10.1111/j.1365- 2982.2010.01667.x
24. Ware J. E., Kosinski M., Keller S. D. SF-36 Physical and Mental Health Summary Scales: A User’s Manual. Boston, MA: The Health Institute, 1994.
25. Welén K., Faresjö Å., Faresjö T. Functional dyspepsia affects women more than men in daily life: A case-control study in primary care. Gender Medicine. 2008;5(1): 62-73. https://doi.org/10.1016/s1550-8579(08)80009-5

Keywords: irritable bowel syndrome, extraintestinal manifestations, motilin, vasointestinal peptid, somatostatin


Founders:
Stavropol State Medical Academy
Pyatigorsk State Research Institute of Balneotherapeutics
Pyatigorsk State Pharmaceutical Academy